Literature DB >> 7805259

Molecular basis of familial cardiomyopathies.

K Schwartz1, L Carrier, P Guicheney, M Komajda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7805259     DOI： 10.1161/01.cir.91.2.532

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  24 in total

1.  The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.

Authors:  B J Maron
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  Differential responses of induced pluripotent stem cell-derived cardiomyocytes to anisotropic strain depends on disease status.

Authors:  Young Wook Chun; David E Voyles; Rutwik Rath; Lucas H Hofmeister; Timothy C Boire; Henry Wilcox; Jae Han Lee; Leon M Bellan; Charles C Hong; Hak-Joon Sung
Journal:  J Biomech       Date:  2015-10-08       Impact factor: 2.712

Review 3.  Mandatory ECG screening of athletes: is this question now resolved?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2011-12-01       Impact factor: 11.136

4.  Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Elif Elmas; Christina Doesch; Stephan Fluechter; Miriam Freundt; Christel Weiss; Siegfried Lang; Thorsten Kälsch; Dariush Haghi; Jana Papassotiriou; Jan Kunde; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-26       Impact factor: 2.357

Review 5.  Recent and ongoing selection in the human genome.

Authors:  Rasmus Nielsen; Ines Hellmann; Melissa Hubisz; Carlos Bustamante; Andrew G Clark
Journal:  Nat Rev Genet       Date:  2007-11       Impact factor: 53.242

6.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

7.  Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene.

Authors:  B Yu; J A French; L Carrier; R W Jeremy; D R McTaggart; M R Nicholson; B Hambly; C Semsarian; D R Richmond; K Schwartz; R J Trent
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

8.  The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; N D Epstein; J R Sellers
Journal:  J Muscle Res Cell Motil       Date:  1997-06       Impact factor: 2.698

9.  Genetic factors in familial hypertrophic cardiomyopathy: does molecular cardiology offer new perspectives?

Authors:  M Komajda
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

Review 10.  Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.

Authors:  C van der Lee; M J Kofflard; M L Geleijnse; F J Ten Cate
Journal:  Neth Heart J       Date:  2005-12       Impact factor: 2.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.